...
首页> 外文期刊>International journal of molecular medicine >Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets
【24h】

Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets

机译:内源性GLP-1是抵抗胰岛脂毒性的关键自卫分子

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The number of pro-α?cells is known to increase in response to β?cell injury and these cells then generate glucagon-like peptide-1?(GLP-1), thus attenuating the development of diabetes. The aim of the present study was to further examine the role and the mechanisms responsible for intra-islet GLP-1 production as a self-protective response against lipotoxicity. The levels of the key enzyme, prohormone convertase?1/3?(PC1/3), as well as the synthesis and release of GLP-1 in models of lipotoxicity were measured. Furthermore, islet viability, apoptosis, oxidative stress and inflammation, as well as islet structure were assessed after altering GLP-1 receptor signaling. Both prolonged exposure to palmitate and a high-fat diet facilitated PC1/3 expression, as well as the synthesis and release of GLP-1 induced by β?cell injury and the generation of pro-α?cells. Prolonged exposure to palmitate increased reactive oxygen species?(ROS) production, and the antioxidant, N-acetylcysteine?(NAC), partially prevented the detrimental effects induced by palmitate on β?cells, resulting in decreased GLP-1 levels. Furthermore, the inhibition of GLP-1 receptor?(GLP-1R) signaling by treatment with exendin?(9-39) further decreased cell viability, increased cell apoptosis and caused a stronger inhibition of the β?cell-specific transcription factor, pancreatic duodenal homeobox?1?(PDX1). Moreover, treatment with the GLP-1R agonist, liraglutide, normalized islet structure and function, resulting in a decrease in cell death and in the amelioration of β?cell marker expression. Importantly, liraglutide maintained the oxidative balance and decreased inflammatory factor and p65 expression. Overall, our data demonstrate that an increase in the number of pro-α?cells and the activation of the intra-islet GLP-1 system comprise a self-defense mechanism for enhancing β?cell survival to combat lipid overload, which is in part mediated by oxidative stress and inflammation.
机译:已知前αα细胞的数目响应于βα细胞损伤而增加,然后这些细胞产生胰高血糖素样肽-1β(GLP-1),从而减弱了糖尿病的发展。本研究的目的是进一步检查胰岛内GLP-1产生的作用和机制,作为针对脂毒性的自我保护反应。测定了脂毒性模型中关键酶,激素原转化酶α1/3β(PC1 / 3)的水平以及GLP-1的合成和释放。此外,在改变GLP-1受体信号后,评估了胰岛的活力,凋亡,氧化应激和炎症以及胰岛的结构。长时间暴露于棕榈酸酯和高脂饮食都促进了PC1 / 3的表达,并促进了β?细胞损伤诱导的GLP-1的合成和释放以及前α?细胞的产生。长时间接触棕榈酸酯会增加活性氧(ROS)的产生,而抗氧化剂N-乙酰半胱氨酸(NAC)则部分阻止了棕榈酸酯对β?细胞产生的有害作用,从而导致GLP-1水平降低。此外,用exendin?(9-39)处理可抑制GLP-1受体β(GLP-1R)信号转导,进一步降低细胞活力,增加细胞凋亡,并更强地抑制胰岛ββ细胞特异性转录因子。十二指肠同源盒1(PDX1)。此外,用GLP-1R激动剂利拉鲁肽治疗可使胰岛结构和功能正常化,从而减少细胞死亡并改善β?细胞标记物的表达。重要的是,利拉鲁肽可维持氧化平衡并降低炎症因子和p65表达。总体而言,我们的数据表明,前α?细胞数量的增加和胰岛内GLP-1系统的激活构成了增强β?细胞存活以抵抗脂质超负荷的自卫机制,这部分是由于由氧化应激和炎症介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号